CTHRC1 and liver cancer: High CTHRC1 expression was associated with shorter OS (P = 0.002) and DSS (P = 0.0097), but was not associated with RFS (P = 0.19) or PFS (P = 0.12) for patients with liver cancer (Fig. 3c).